OpenAlex
PricingAboutJobs
Log inGet started
Work

Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review

HTML

Year: 2022
Type: review
Study design: Systematic Review
Source: Expert Review of Pharmacoeconomics & Outcomes Research
DOI: 10.1080/14737167.2022.2130761
Authors: Ghader Mohammadnezhad, Behniya Azadmehr, Nazila Yousefi
Institutions: Shahid Beheshti University, Shahid Beheshti University of Medical Sciences
Language: English

Topic: Urinary Bladder and Prostate Research
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Keywords: mirabegron, overactive bladder, cost-effectiveness, antimuscarinic agents, oxybutynin, fesoterodine, tolterodine, darifenacin, trospium, beta3-adrenergic agonists, quality-adjusted life years, incremental cost-effectiveness ratio, pharmacotherapy
SDG: Good health and well-being

Open Access status: closed

Funder: Shahid Beheshti University of Medical Sciences
OpenAlex ID: W4297965543
FWCI: 0.119
Cites: 33
Cited by: 2
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms